PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187956. A total of 2 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $55,000 | -3.5% | 130 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $57,000 | -97.7% | 130 | -96.1% | 0.00% | -96.7% |
| Q2 2015 | $2,513,000 | +25.1% | 3,369 | +0.3% | 0.09% | +9.5% |
| Q1 2015 | $2,009,000 | +3918.0% | 3,359 | +2770.9% | 0.08% | +4100.0% |
| Q2 2014 | $50,000 | -59.0% | 117 | -60.7% | 0.00% | -71.4% |
| Q1 2014 | $122,000 | -23.3% | 298 | 0.0% | 0.01% | -30.0% |
| Q4 2013 | $159,000 | – | 298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 82,300 | $521,000 | 0.01% |
| SIMPLEX TRADING, LLC | 39 | $1,000 | 0.00% |